Introduction: To effectively clear amyloid β protein(Aβ)in the brain without affecting its amyloid precursor protein(APP)is a key point to break through the main bottlenecks in the immunotherapy for Alzheimers Disease(AD).Our previous studies indicated that the sequence 31-35 in Aβ molecule is the shortest active center responsible for the neurotoxicity of Aβ.